Related Experiment Video
Updated: Jul 16, 2025

Dual CRISPR-Interference Strategy for Targeting Synthetic Lethal Interactions Between Non-Coding RNAs in Cancer Cells
Published on: May 30, 2025
Precise Interference of RNA-Protein Interaction by CRISPR-Cas13-Mediated Peptide Competition
Meng Li1, Dan Li1, Leiruo Lin1
1Molecular Cancer Research Center, School of Medicine, Shenzhen Campus of Sun Yat-sen University, Sun Yat-sen University, Shenzhen 518107, China.
Abstract:
RNA-protein interactions are essential nodes of cellular regulatory circuits and play critical roles in normal physiology and disease. However, the precise roles of individual RNA-protein interactions remain elusive. Here we report a method for precise interference of endogenous RNA interacting with the RNA binding protein (RBP). TTP is an RBP that recognizes the AU-rich element (ARE) of mRNA via the binding domain TZF and represses gene expression. We engineer Cas13b, a class 2 type VI CRISPR-Cas endonuclease that exclusively targets RNA, to direct the peptide of TZF to the binding site and compete with endogenous TTP. We show that this tool specifically interferes with TTP interacting with the PIM1 and IL-2 3' UTR under the guidance of the gRNA specific for the AREs. Further, precise interference with the TTP-PIM1 interaction exerts a distinct effect on cell proliferation compared to transcriptome-wide interference. Thus, our work establishes a tool for deep understanding of RNA-RBP interactions.
Insights
Researchers developed a new CRISPR-based tool to precisely disrupt specific RNA-protein interactions. This method allows for a deeper understanding of how these interactions regulate gene expression and cellular processes in health and disease.
Area of Science:
- Molecular Biology
- Gene Regulation
- Biotechnology
Background:
- RNA-protein interactions are crucial for cellular regulation but their specific roles are often unclear.
- The protein TTP binds to AU-rich elements (AREs) on mRNA via its TZF domain, repressing gene expression.
Purpose of the Study:
- To develop a novel tool for precise interference of endogenous RNA-protein interactions.
- To investigate the specific functions of RNA-binding protein (RBP) interactions in cellular processes.
Main Methods:
- Engineered the CRISPR-Cas13b system to target specific RNA molecules.
- Utilized a guide RNA (gRNA) to direct the TZF domain of TTP to compete with endogenous TTP binding sites on target mRNAs.
- Interfered with TTP interactions with PIM1 and IL-2 3' UTRs.
Main Results:
- Demonstrated specific interference with TTP binding to the AREs of PIM1 and IL-2 mRNAs.
- Showed that precise interference with the TTP-PIM1 interaction had a distinct effect on cell proliferation compared to broad transcriptome interference.
Conclusions:
- Established a novel CRISPR-based tool for precise RNA-protein interaction interference.
- This tool enables a deeper understanding of the specific roles of individual RNA-RBP interactions in cellular regulation and disease.
Related Concept Videos
CRISPR
CRISPR and crRNAs
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
CRISPR/Cas9 Genome Editing
The Antiviral System of Bacteria and Archaea: CRISPR
Protein-protein Interfaces

